Latest market price
199.47
-2.27-1.13%
News
Down 1.1% — Philip Morris Q3: ZYN Is Growing Again, But It's Costing More (seekingalpha.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 29.12 | EPS (ttm) | 6.85 | Insider Own | 0.40% | Shs Outstand | 1.56B | Perf Week | -2.79% |
| Market Cap | 310.90B | Forward P/E | 21.96 | EPS next Y | 9.08 | Insider Trans | 0.00% | Shs Float | 1.56B | Perf Month | 4.16% |
| Enterprise Value | 351.77B | PEG | 2.98 | EPS next Q | - | Inst Own | 63.17% | Short Float | 1.14% | Perf Quarter | 1.95% |
| Income | 10.71B | P/S | 7.21 | EPS this Y | 10.97% | Inst Trans | 0.00% | Short Ratio | 3.80 | Perf Half Y | 21.48% |
| Sales | 43.14B | P/B | - | EPS next Y | 8.81% | ROA | 16.05% | Short Interest | 17.75M | Perf YTD | 24.36% |
| Book/sh | -3.81 | P/C | 46.52 | EPS next 5Y | 9.63% | ROE | -119.68% | 52W High | 210.46 -5.22% | Perf Year | 27.16% |
| Cash/sh | 4.29 | P/FCF | 22.87 | EPS past 3/5Y | 7.71% 7.07% | ROIC | 27.48% | 52W Low | 142.11 40.36% | Perf 3Y | 114.00% |
| Dividend Est. | 6.40 (3.21%) | EV/EBITDA | 18.76 | Sales past 3/5Y | 8.57% 7.21% | Gross Margin | 67.74% | Volatility | 2.71% 2.49% | Perf 5Y | 102.78% |
| Dividend TTM | 6.01 (3.01%) | EV/Sales | 8.15 | EPS Y/Y TTM | 51.55% | Oper. Margin | 38.62% | ATR (14) | 5.38 | Perf 10Y | 107.35% |
| Dividend Ex-Date | Oct 02, 2026 | Quick Ratio | 0.61 | Sales Y/Y TTM | 13.89% | Profit Margin | 24.82% | RSI (14) | 54.00 | Recom | 2.36 |
| Dividend Gr. 3/5Y | 3.82% 3.54% | Current Ratio | 1.02 | EPS Q/Q | 5.36% | SMA20 | 1.25% | Beta | 0.38 | Target Price | 213.67 |
| Payout | 85.89% | Debt/Eq | 10.52 | Sales Q/Q | 5.47% | SMA50 | 3.60% | Rel Volume | 0.77 | Prev Close | 201.74 |
| Employees | 84,900 | LT Debt/Eq | -5.62 | Earnings | Feb 05 | SMA200 | 10.28% | Avg Volume | 4.61M | Price | 199.47 |
| IPO Date | Mar 17, 2008 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.77% 1.07% | Net Debt/EBITDA | 2.18 | Volume | 3,533,754 | Change | -1.13% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-22-26 | Reiterated | UBS | Neutral | $192 → $201 |
| Sep-23-26 | Reiterated | UBS | Neutral | $182 → $192 |
| Jul-29-26 | Reiterated | Barclays | Overweight | $205 → $225 |
| Jul-24-26 | Reiterated | BTIG | $216 → $221 | |
| Jul-23-26 | Reiterated | Stifel Nicolaus | Buy | $195 → $205 |
| Jul-23-26 | Reiterated | Morgan Stanley | Overweight | $200 → $215 |
| Jul-23-26 | Reiterated | Needham | Buy | $215 |
| Jul-21-26 | Initiated | BTIG | Buy | $216 |
| Jul-02-26 | Reiterated | UBS | Neutral | $168 → $182 |
| Jun-03-26 | Reiterated | Morgan Stanley | Overweight | $190 → $200 |
Latest News· Times ET
Oct-23-26
Oct-23-2612:01AM
Oct-22-26
09:25AM
Oct-21-26
02:20PM
01:05PM
Philip Morris International Q3 Earnings Call Highlightsmarketbeat.com
11:51AM
09:07AM
Stock Futures Climb Higher Following SpaceX Earningsschaeffersresearch.com
07:49AM
07:40AM
07:30AM
07:12AM
06:59AM
Oct-19-26
Oct-17-26
Oct-17-2603:25AM
Company
Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicotine. Its primary business involves both conventional cigarettes and an expanding array of smoke-free alternatives, such as innovative heat-not-burn devices, vapor products, and oral nicotine solutions. These offerings are distributed in markets worldwide, with the exception of the United States. The smoke-free portfolio includes brands like HEETS (encompassing Creations, Dimensions, Marlboro variants), Parliament HeatSticks, and TEREA, in addition to KT&G-licensed brands Fiit and Miix. For conventional cigarettes, the company sells internationally recognized brands such as Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris. Regionally, it also owns major cigarette brands like Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia, and Fortune and Jackpot in the Philippines. PMI's smoke-free innovations are currently available across 71 global markets. Established in 1987, Philip Morris International Inc. is headquartered in New York, New York.
Ownership
Total institutional ownership63.17%
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 43,138 | 40,648 | 37,878 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 13,918 | 13,366 | 13,329 | — | — | — | — | — | — | |
| Gross Profit | 29,220 | 27,282 | 24,549 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 12,260 | 10,556 | 11,147 | — | — | — | — | — | — | |
| Research and Development | 0 | 756 | 759 | — | — | — | — | — | — | |
| Other Operating Expense | 298 | 1,078 | -759 | — | — | — | — | — | — | |
| Operating Income | 16,662 | 14,892 | 13,402 | — | — | — | — | — | — | |
| Interest Expense | 1,518 | 1,587 | 1,763 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -75 | 1,280 | 560 | — | — | — | — | — | — | |
| Net Income Before Taxes | 15,069 | 14,585 | 12,199 | — | — | — | — | — | — | |
| Income Taxes | 3,292 | 2,737 | 2,380 | — | — | — | — | — | — | |
| Consolidated Net Income | 10,709 | 11,348 | 7,034 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 11,777 | 11,848 | 9,819 | — | — | — | — | — | — | |
| Net Income | 10,709 | 11,348 | 7,034 | — | — | — | — | — | — | |
| EPS (Recurring) | 6.85 | 7.27 | 4.53 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 6.85 | 7.27 | 4.53 | — | — | — | — | — | — | |
| EPS (Diluted) | 6.85 | 7.26 | 4.52 | — | — | — | — | — | — | |
| EBITDA | 18,755 | 18,722 | 15,749 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 29.12 | 22.09 | 26.63 | — | — | — | — | — | — | |
| Price To Sales Ratio | 7.23 | 6.14 | 4.94 | — | — | — | — | — | — | |
| Gross Margin | 67.74 | 67.12 | 64.81 | — | — | — | — | — | — | |
| Operating Margin | 38.62 | 36.64 | 35.38 | — | — | — | — | — | — | |
| Net Margin | 24.82 | 27.92 | 18.57 | — | — | — | — | — | — | |
| Shares Outstanding | 1,563 | 1,556 | 1,554 | — | — | — | — | — | — | |
| Market Capitalization | 311,772 | 249,582 | 187,024 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dobrowolski Reginaldo | Group Controller | Feb 20 '26 | Sale | 183.48 | 6,000 | 1,100,880 | 7,254 | Feb 20 |
| Kennedy Stacey | CEO PMI U.S. | Feb 20 '26 | Sale | 183.13 | 14,350 | 2,627,916 | 45,301 | Feb 20 |
| Olczak Jacek | Group CEO PMI | Feb 19 '26 | Sale | 182.18 | 80,000 | 14,574,400 | 632,344 | Feb 20 |
| De Wilde Frederic | CEO PMI International | Feb 19 '26 | Sale | 182.58 | 20,000 | 3,651,600 | 133,513 | Feb 20 |
| Guerin Yann | Group Chief Legal Officer | Feb 19 '26 | Sale | 181.69 | 4,000 | 726,760 | 34,412 | Feb 20 |
| Babeau Emmanuel | Group Chief Financial Officer | Feb 19 '26 | Sale | 181.61 | 33,800 | 6,138,418 | 164,463 | Feb 20 |
| Dahlgren Lars | Pres. Smoke-Free Oral Products | Mar 06 '25 | Sale | 152.96 | 3,679 | 562,740 | 26,828 | Mar 07 |
| Andolina Massimo | President, Europe Region | Feb 24 '25 | Sale | 156.05 | 17,500 | 2,730,875 | 86,737 | Feb 25 |
| Guerin Yann | SVP & General Counsel | Feb 20 '25 | Sale | 151.28 | 2,500 | 378,200 | 30,308 | Feb 21 |
| Calantzopoulos Andre | director, other: Chairman | Feb 20 '25 | Sale | 149.06 | 40,643 | 6,058,246 | 561,349 | Feb 21 |
| Olczak Jacek | Chief Executive Officer | Feb 20 '25 | Sale | 148.87 | 40,000 | 5,954,800 | 547,426 | Feb 21 |
| Barth Werner | Pr.Combusibles&GlobalComb.Mktg | Feb 20 '25 | Sale | 148.67 | 10,000 | 1,486,700 | 106,244 | Feb 21 |
| Babeau Emmanuel | Chief Financial Officer | Feb 20 '25 | Sale | 148.85 | 30,000 | 4,465,500 | 139,105 | Feb 21 |
| Dobrowolski Reginaldo | Vice President and Controller | Feb 12 '25 | Sale | 149.70 | 8,000 | 1,197,630 | 7,596 | Feb 13 |
| De Wilde Frederic | Pr SSEA CIS & MEA Region | Feb 07 '25 | Sale | 144.54 | 15,000 | 2,168,100 | 128,909 | Feb 07 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.